{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(7)"],"submitter":["EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA)"],"pubmed_abstract":["Following an application from DuPont Nutrition Biosciences ApS submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bi-07 (Bi-07) and contribution to increasing lactose digestion. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Bi-07. The Panel considers that Bi-07 is sufficiently characterised. The claimed effect proposed by the applicant is 'improvem"],"journal":["EFSA journal. European Food Safety Authority"],"pagination":["e06198"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388145"],"repository":["biostudies-literature"],"pubmed_title":["<i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006."],"pmcid":["PMC7388145"],"pubmed_authors":["Kearney J","Vinceti M","Naska A","Castenmiller J","Pelaez C","McArdle HJ","Tsabouri S","Mangelsdorf I","Knutsen HK","Thies F","EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA)","Maciuk A","De Henauw S","Pentieva K","Turck D","Hirsch-Ernst KI","Siani A","S Bresson JL"],"additional_accession":[]},"is_claimable":false,"name":"<i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.","description":"Following an application from DuPont Nutrition Biosciences ApS submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bi-07 (Bi-07) and contribution to increasing lactose digestion. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Bi-07. The Panel considers that Bi-07 is sufficiently characterised. The claimed effect proposed by the applicant is 'improvem","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jul","modification":"2025-04-03T22:14:09.477Z","creation":"2020-11-19T13:33:19Z"},"accession":"S-EPMC7388145","cross_references":{"pubmed":["32742434"],"doi":["10.2903/j.efsa.2020.6198"]}}